Contract 75F40122P00096
Fujifilm Cellular Dynamics, Inc · Department Of Health And Human Services · April 19, 2022
Fujifilm Cellular Dynamics, Inc was awarded a federal contract by Department Of Health And Human Services (Food And Drug Administration) on April 19, 2022 for $99,000 of work in biological product (except diagnostic) manufacturing. Performance is in Silver Spring, MD. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on July 22, 2024.
Contract details
- PIID
- 75F40122P00096
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed
- NAICS
- 325414 · Biological Product (Except Diagnostic) Manufacturing
- Product / service
- General Science And Technology R&D Services; General Science And Technology; Applied Research
- Place of performance
- Silver Spring, MD
- First action
- April 19, 2022
- Latest action
- July 22, 2024
Description
THE PURCHASE OF CARDIOMYOCYTES
Modification timeline
-
July 22, 2024Mod P00001$-85
-
April 19, 2022Base award$98.8K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Bio-Rad Laboratories, Inc. | Department Of Health And Human Services | March 31, 2026 | $20.6K |
| Georgia Tech Research Corp | Department Of Health And Human Services | March 28, 2026 | $145.8K |
| Seqirus Inc | Department Of Health And Human Services | March 25, 2026 | $23.7K |
| Seqirus Inc | Department Of Health And Human Services | March 24, 2026 | $0 |
| Battelle Memorial Institute | Department Of Health And Human Services | March 19, 2026 | $2.80M |
| Sanofi Vaccines Us Inc. | Department Of Health And Human Services | March 19, 2026 | $53.21M |
Top contractors in NAICS 325414
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Pfizer Inc | 3 | $15.27B |
| 2 | Sanofi Vaccines Us Inc. | 606 | $9.38B |
| 3 | Regeneron Pharmaceuticals Inc | 1 | $5.57B |
| 4 | Merck Sharp & Dohme Corp. | 56 | $3.99B |
| 5 | Emergent Biodefense Operations Lansing Llc | 16 | $3.34B |
| 6 | Merck Sharp & Dohme Llc | 15 | $3.33B |
| 7 | Pfizer Inc. | 25 | $3.11B |
| 8 | Glaxosmithkline Holdings (Americas) Inc. | 109 | $2.24B |
| 9 | Modernatx, Inc. | 1 | $1.75B |
| 10 | Bavarian Nordic A/S | 1 | $1.01B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75F40122P00096?
Contract 75F40122P00096 is a federal contract awarded to Fujifilm Cellular Dynamics, Inc by Department Of Health And Human Services on April 19, 2022 for $99,000 of work classified under BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING. It has been modified 1 time since the base award.
Who won contract 75F40122P00096?
Fujifilm Cellular Dynamics, Inc won contract 75F40122P00096 from Department Of Health And Human Services.
How much is contract 75F40122P00096 worth?
Contract 75F40122P00096 has obligated $99,000 to date.